Why is Boston Scientific Stock Trading Lower On Wednesday? - Boston Scientific ( NYSE:BSX )
On Wednesday, Boston Scientific Corporation BSX released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe, symptomatic aortic stenosis at risk of open-heart surgery.
| Ticker |
Sentiment |
Impact |
|
MDT
|
Neutral
|
18 %
|
|
BSX
|
Neutral
|
35 %
|
|
EW
|
Neutral
|
18 %
|
